New phase 3 analyses show that a single dose of REGEN-COV (casirivimab and imdevimab) provides long-term protection against covid-19

https://investor.regeneron.com/news-releases/news-release-details/new-phase-3-analyses-show-single-dose-regen-covr-casirivimab-and
Regeneron
November 8, 2021